AMY SURMAN: Open Payments
NPI 1225079122 · CHATHAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$977 in 54 payments from 14 companies in 2025. Trend: 2023 $1,183 · 2024 $1,510 · 2025 $977
Food & beverage: $977
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $168 |
| GlaxoSmithKline, LLC. | 10 | $161 |
| Amgen Inc. | 9 | $135 |
| PFIZER INC. | 4 | $93 |
| Novo Nordisk Inc | 4 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $71 |
| Lilly USA, LLC | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| Kowa Pharmaceuticals America, Inc. | 2 | $36 |
Products named: TRELEGY ELLIPTA, UBRELVY, Kerendia, EVENITY, MOUNJARO, OTEZLA, PREVNAR 20, QULIPTA.
Industry payments across NY — which companies pay providers there.
